These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34293472)

  • 21. Potential chitosan-coated alginate nanoparticles for ocular delivery of daptomycin.
    Costa JR; Silva NC; Sarmento B; Pintado M
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1255-62. PubMed ID: 25754770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of intravitreal triamcinolone acetonide injection with and without preservative.
    Maia M; Farah ME; Belfort RN; Penha FM; Lima Filho AA; Aggio FB; Belfort R
    Br J Ophthalmol; 2007 Sep; 91(9):1122-4. PubMed ID: 17383993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a dual delivery of levofloxacin and prednisolone acetate via PLGA nanoparticles/ thermosensitive chitosan-based hydrogel for postoperative management: An in-vitro and ex-vivo study.
    Cheng YH; Chang YF; Ko YC; Liu CJ
    Int J Biol Macromol; 2021 Jun; 180():365-374. PubMed ID: 33676980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degeneration.
    Hirani A; Grover A; Lee YW; Pathak Y; Sutariya V
    Pharm Dev Technol; 2016; 21(1):61-7. PubMed ID: 25259682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M; Li X; Liu J; Han Y; Cheng L
    J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitreous wick syndrome--a potential cause of endophthalmitis after intravitreal injection of triamcinolone through the pars plana.
    Chen SD; Mohammed Q; Bowling B; Patel CK
    Am J Ophthalmol; 2004 Jun; 137(6):1159-60; author reply 1160-1. PubMed ID: 15183823
    [No Abstract]   [Full Text] [Related]  

  • 27. Polymeric micelles for the ocular delivery of triamcinolone acetonide: preparation and
    Safwat MA; Mansour HF; Hussein AK; Abdelwahab S; Soliman GM
    Drug Deliv; 2020 Dec; 27(1):1115-1124. PubMed ID: 32720545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of controlled-release triamcinolone acetonide-loaded mPEG-PLGA nanoparticles in treating experimental autoimmune uveitis.
    Guo D; Li Q; Sun Y; Guo J; Zhao Q; Yin X; Wei H; Wu S; Bi H
    Nanotechnology; 2019 Apr; 30(16):165702. PubMed ID: 30641491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Onset of an outbreak of Bipolaris hawaiiensis fungal endophthalmitis after intravitreal injections of triamcinolone.
    Small KW; Chan CK; Silva-Garcia R; Walsh TJ
    Ophthalmology; 2014 Apr; 121(4):952-8. PubMed ID: 24507858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased incidence of sterile endophthalmitis following intravitreal preserved triamcinolone acetonide.
    Jonisch J; Lai JC; Deramo VA; Flug AJ; Fastenberg DM
    Br J Ophthalmol; 2008 Aug; 92(8):1051-4. PubMed ID: 18653598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GRAM-NEGATIVE BACTERIA FROM PATIENTS WITH ENDOPHTHALMITIS: DISTRIBUTION OF ISOLATES AND ANTIMICROBIAL SUSCEPTIBILITIES.
    Wilson BD; Relhan N; Miller D; Flynn HW
    Retin Cases Brief Rep; 2019 Winter; 13(1):54-56. PubMed ID: 28134741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections.
    Cheung CS; Wong AW; Lui A; Kertes PJ; Devenyi RG; Lam WC
    Ophthalmology; 2012 Aug; 119(8):1609-14. PubMed ID: 22480743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection.
    Moshfeghi DM; Kaiser PK; Bakri SJ; Kaiser RS; Maturi RK; Sears JE; Scott IU; Belmont J; Beer PM; Quiroz-Mercado H; Mieler WF
    Ophthalmic Surg Lasers Imaging; 2005; 36(1):24-9. PubMed ID: 15688968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial endophthalmitis after triamcinolone acetonide-assisted pars plana vitrectomy.
    Mitamura Y; Miyano N; Ohtsuka K
    Jpn J Ophthalmol; 2005; 49(6):538-539. PubMed ID: 16365807
    [No Abstract]   [Full Text] [Related]  

  • 35. Episcleral drug film for better-targeted ocular drug delivery and controlled release using multilayered poly-ε-caprolactone (PCL).
    Sun S; Li J; Li X; Lan B; Zhou S; Meng Y; Cheng L
    Acta Biomater; 2016 Jun; 37():143-54. PubMed ID: 27071973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol.
    Deng F; Hu W; Chen H; Tang Y; Zhang L
    Curr Drug Deliv; 2018; 15(4):594-600. PubMed ID: 28425869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone.
    Sheyman AT; Cohen BZ; Friedman AH; Ackert JM
    JAMA Ophthalmol; 2013 Jul; 131(7):864-9. PubMed ID: 23640384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute endophthalmitis after intravitreal injection and preventive effect of preoperative topical antibiotics.
    Park Y; Kim KS; Park YH
    J Ocul Pharmacol Ther; 2013 Dec; 29(10):900-5. PubMed ID: 24067061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cataract surgery combined with intravitreal injection of triamcinolone acetonide.
    Jonas JB; Kreissig I; Budde WM; Degenring RF
    Eur J Ophthalmol; 2005; 15(3):329-35. PubMed ID: 15945000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates.
    Anand AR; Therese KL; Madhavan HN
    Indian J Ophthalmol; 2000 Jun; 48(2):123-8. PubMed ID: 11116508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.